June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Long-term comparative effectiveness of telemedicine to detect diabetic retinopathy
Author Affiliations & Notes
  • Steven Mansberger
    Devers Eye Institute, Portland, OR
    Public Health and Preventive Medicine, Oregon Health & Science University, Portland, OR
  • Stuart Gardiner
    Devers Eye Institute, Portland, OR
  • Shaban Demirel
    Devers Eye Institute, Portland, OR
  • Thomas Becker
    Public Health and Preventive Medicine, Oregon Health & Science University, Portland, OR
  • Footnotes
    Commercial Relationships Steven Mansberger, Merck (R), Alcon (C), Allergan (C), Allergan (F), Merck (F), Santen (C), Glaukos (C); Stuart Gardiner, Allergan (R); Shaban Demirel, Carl Zeiss Meditec (F), Heidelberg Engineering (R), Heidelberg Engineering (F); Thomas Becker, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1549. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Steven Mansberger, Stuart Gardiner, Shaban Demirel, Thomas Becker; Long-term comparative effectiveness of telemedicine to detect diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1549.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine the long-term comparative effectiveness of telemedicine for providing diabetic retinopathy screening exams in community health clinics with a high proportion of minorities including American Indian/Alaska Natives.

Methods: We enrolled 567 participants with diabetes into a multicenter, randomized controlled trial with a staged intervention. We assigned diabetic participants to one of two groups: 1) telemedicine with a non-mydriatic camera in a primary medical clinic; or 2) traditional surveillance with an eye care provider. After two years, the trial offered telemedicine to all participants. We determined the proportion of diabetic retinopathy screening exams during each year after enrollment using an intention-to-treat analysis. We graded diabetic retinopathy using a validated scale from Stage 0 (none) to Stage 4 (proliferative diabetic retinopathy).

Results: The Telemedicine group (n=296) was more likely to receive a diabetic screening exam when compared to the Traditional Surveillance group (n=271) during Year 1 (91.9 vs. 43.9%, P<.001), and Year 2 (53.0 vs. 33.2%, P<.001). However, after the trial offered telemedicine to both groups, the proportion of diabetic screening exams was similar between groups for the subsequent years (Year 3, 44.3 vs. 39.5%, P=.25; Year 4, 45.9 vs. 46.1%, P=.96; Year 5, 47.6 vs. 51.3%, P=.38). Using a cut-off of ‘moderate diabetic retinopathy or worse’ as requiring referral to an ophthalmologist, only 8.3%, 6.2%, 3.9%, 6.4%, and 5.2% of participant would require referral during Year 1, 2, 3, 4, and 5, respectively.

Conclusions: Telemedicine in the primary medical clinic using non-mydriatic cameras increased the proportion of participants who obtained diabetic screening exams when compared to traditional surveillance, and most patients did not have levels of diabetic retinopathy requiring a referral to an ophthalmologist. Telemedicine may be a more effective way to screen patients for diabetic retinopathy, and to triage further evaluation with an eye care provider when compared to traditional surveillance by an eye care provider. The staged intervention suggests that telemedicine would increase the proportion of diabetic screening exams over the long-term, but the decrease in the proportion of diabetic screening exam in both groups suggests that other barriers to diabetic screening exist even when telemedicine is available.

Keywords: 460 clinical (human) or epidemiologic studies: health care delivery/economics/manpower • 466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • 499 diabetic retinopathy  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×